Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-021972

Chief Executive Officer sold 7,800 shares at an average $38.66 ($301,546)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ciechanover Isaac E. Chief Executive Officer 2019-03-28 Sale −2,000 $36.75 $73,500 325,737 I: show line 1 in the form
Ciechanover Isaac E. Chief Executive Officer 2019-03-28 Sale −1,600 $38.02 $60,832 324,137 I: show line 2 in the form
Ciechanover Isaac E. Chief Executive Officer 2019-03-28 Sale −300 $38.59 $11,577 323,837 I: show line 3 in the form
Ciechanover Isaac E. Chief Executive Officer 2019-03-29 Sale −3,700 $39.81 $147,297 320,137 I: show line 4 in the form
Ciechanover Isaac E. Chief Executive Officer 2019-03-29 Sale −200 $41.70 $8,340 319,937 I: show line 5 in the form
Open-market sales · 7,800 sh · avg $38.66 · $301,546
Loading xslF345X03/doc4.xml…